Venture Catalysts leads seed round in Aikenist

Gen-AI-based smart workflow solutions provider Aikenist has raised a seed round led by Venture Catalysts for an undisclosed amount. 

The funding round saw participation from several notable investors, including MARL Fund, Quant Fund, C-CAMP, Nandak Growth Catalysts, and angel investors, bringing valuable expertise and resources to support Aikenist's growth trajectory.

Founded by Ashwin Amarapur,  Aikenist  provides AI-accelerated magnetic resonance imaging (MRIs) for diagnostic centers and hospitals. Aikenist aims to provide advanced AI-based solutions for faster MRI scanning, better diagnosis capability, and turnaround to reach the benefits of medical imaging to a larger population for regular checkups of critical illnesses like cancer, Alzheimer's, and common MSK problems. 

The firm’s SaaS business model, with annual pricing or pay-per-use options, provides flexibility for healthcare providers of all sizes, from small clinics to large hospital networks.

Aikenist's flagship product, QuickSuite, optimizes end-to-end radiology processes, including scan acquisition, analysis, and reporting/sharing of scan data. The solution comprises QuickRad, an AI-powered PACS & RIS system; QuickScan, a patented solution for faster MRI scanning; and QuickDiag, which includes specialized suites for disease detection and quantification.